 TEL-AVIV, ISRAEL and RALEIGH, NC ACCESSWIRE October 18, 2021 RedHill Biopharma Ltd. Nasdaq: RDHL RedHill or the Company, a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the Companys Chairman CEO, CFO, Chief Commercial Officer, Chief Business Officer and Chief Corporate Business Development Officer, collectively purchased approximately 180,000 American Depositary Shares ADSs of RedHill between mid-September and October 15, 2021 in open-market transactions. 